Echo Street Capital Management LLC Arrowhead Pharmaceuticals, Inc. Transaction History

Echo Street Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$23.68 - $38.51 $219,229 - $356,525	9,258 New	9,258 $235,000
Q3 2022 Nov 14, 2022	BUY	$29.63 - $48.31 $299,707 - $488,655	10,115 New	10,115 $334,000
Q1 2022 May 16, 2022	SELL	$39.62 - $69.97 $315,414 - $557,031	-7,961 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $462,454 - $656,862	7,961 New	7,961 $528,000
Q3 2021 Nov 15, 2021	SELL	$58.38 - $84.96 $561,790 - $817,570	-9,623 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$62.15 - $90.32 $598,069 - $869,149	9,623 New	9,623 $797,000

295

91.1M

155K

426K

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $1.96B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

Get notified when there are updates to the investment portfolio of Echo Street Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Echo Street Capital Management LLC with notifications on news.